Related Experiment Video
Updated: Jun 30, 2026
06:08
Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay
Published on: September 22, 2023
Mucosal regulatory T cells in airway hyperresponsiveness
D Strickland1, M Wikstrom, D Turner
1Telethon Institute for Child Health Research and Centre for Child Health Research, School of Paediatrics and Child Health, The University of Western Australia, Perth, WA, Australia.
Chemical Immunology and Allergy
|September 20, 2008
Summary
Regulatory T cells (Treg) are crucial for immune regulation, particularly in the airways. Their numbers may inhibit airway hyperresponsiveness and asthma exacerbations.
Area of Science:
- Immunology
- Respiratory Medicine
Background:
- The concept of T-cell suppression dates back to the 1970s.
- Regulatory T cells (Treg) have gained significant research interest in the last decade.
- Treg play a role in controlling T-cell-mediated inflammation in various tissues.
Purpose of the Study:
- To discuss the role of Treg in immune regulation within the respiratory mucosa.
- To highlight the importance of Treg in inhibiting airway hyperresponsiveness.
- To explore the link between Treg numbers and asthma exacerbations.
Main Methods:
- This chapter focuses on a discussion of existing concepts and evidence.
- Literature review and synthesis of current research findings.
- Conceptual analysis of Treg function in the respiratory system.
Main Results:
- Evidence suggests Treg are integral to the respiratory mucosal regulatory axis.
- The quantity of Treg in the airways is critical for suppressing airway hyperresponsiveness.
- Treg are implicated in the inhibition of inflammation during asthma exacerbations.
Conclusions:
- Regulatory T cells are fundamental to respiratory immune homeostasis.
- Therapeutic strategies targeting Treg may be beneficial for asthma management.
- Further research into Treg recruitment and function in airways is warranted.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:16Drugs Used in Upper Respiratory Disorders: Overview
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...